# Shilpa Medicare Limited - Inspection Records Source: https://www.keypedia.com/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655 > Inspection records and compliance data for Shilpa Medicare Limited in Polepally, Jadcherla, None. Access full analysis and detailed observations. --- ## Details - Name: Shilpa Medicare Limited - FEI Number: 3009876430 - City: Polepally, Jadcherla - State: None - Country Name: India - Address Line 1: S-20 To S-26, Pharm. Formulation Sez, Tsiic, Green Industrial Park - Zip Code: None - Facility Type: Sterile and non-sterile Drug Manufacturer - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - Shilpa Medicare Limited - Unknown Date](https://www.keypedia.com/records/483/shilpa-medicare-limited/1533339e-2565-4102-a4c6-10f007e2112a) — source: FDA, date: Invalid Date - [CRL - Shilpa Medicare Limited - Unknown Date](https://www.keypedia.com/records/crl/shilpa-medicare-limited/be69043b-06e2-466f-9c9e-69b63f769abd) — source: FDA, date: Invalid Date - [CRL - Shilpa Medicare Limited - Unknown Date](https://www.keypedia.com/records/crl/shilpa-medicare-limited/6423cdf4-cd19-438d-b4f4-f71cf979403b) — source: FDA, date: Invalid Date - [FDA Inspection 1293586 - Shilpa Medicare Limited - 2025-11-21](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/5e052bfe-bb5b-4f70-9128-9b00c83ba684) — source: FDA, date: November 21, 2025 - [483 - Shilpa Medicare Limited - 2025-11-10](https://www.keypedia.com/records/483/shilpa-medicare-limited/d193fbef-a05c-4aef-b2ae-b62c96c8860b) — source: FDA, date: November 10, 2025 - [483 - Shilpa Medicare Limited - 2023-11-09](https://www.keypedia.com/records/483/shilpa-medicare-limited/9019d81e-706a-4c7c-9ff6-ed3f9ed86354) — source: FDA, date: November 9, 2023 - [FDA Inspection 1224070 - Shilpa Medicare Limited - 2023-11-09](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/7da36a5d-fe0d-4110-85d4-2f3655ff4b00) — source: FDA, date: November 9, 2023 - [WARNING_LETTER - Shilpa Medicare Limited - 2020-02-25](https://www.keypedia.com/records/warning_letter/shilpa-medicare-limited/2e18f8c2-80a9-409d-a285-427792df7cb5) — source: FDA, date: February 25, 2020 - [FDA Inspection 1121634 - Shilpa Medicare Limited - 2020-02-25](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/697d1298-32ab-4346-bb72-ace82de70319) — classification: Official Action Indicated (OAI), source: FDA, date: February 25, 2020 - [483 - Shilpa Medicare Limited - 2020-02-13](https://www.keypedia.com/records/483/shilpa-medicare-limited/274dcb0e-51f8-450e-ad76-ee1e970cf10c) — source: FDA, date: February 13, 2020 - [483 - Shilpa Medicare Limited - 2019-09-06](https://www.keypedia.com/records/483/shilpa-medicare-limited/454b93df-428c-4c44-a718-2062133d8ced) — source: FDA, date: September 6, 2019 - [FDA Inspection 1101543 - Shilpa Medicare Limited - 2019-09-06](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/37e8cb63-4ef0-4357-8cf0-a688ed79fa1e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 6, 2019 - [483 - Shilpa Medicare Limited - 2017-11-30](https://www.keypedia.com/records/483/shilpa-medicare-limited/cebe91e8-c966-4b3d-892f-a55312c72fbf) — source: FDA, date: November 30, 2017 - [FDA Inspection 1036712 - Shilpa Medicare Limited - 2017-11-30](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/11c5330b-3d05-4b5e-9662-f17cadc816a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 30, 2017 - [FDA Inspection 1020609 - Shilpa Medicare Limited - 2017-07-28](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/3ddb8f78-d603-4012-b674-1b39a9477513) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2017 - [FDA Inspection 983085 - Shilpa Medicare Limited - 2016-07-26](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/79a1c789-9957-4ef8-a691-bc2336167ab0) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2016 - [FDA Inspection 939599 - Shilpa Medicare Limited - 2015-08-26](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/c16b7ba5-bf12-41c5-838b-ee9e3a7ce042) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2015 ## Related Companies - [Intas Pharmaceuticals Limited](https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8) - [Biocon Biologics Limited](https://www.keypedia.com/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d) - [I3 PHARMACEUTICALS LLC](https://www.keypedia.com/companies/i3-pharmaceuticals-llc/020702e4-1539-47b8-87d9-725035cecbfe) - [GlaxoSmithKline Biologicals](https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808) - [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59) - [Teyro Labs Private Limited](https://www.keypedia.com/companies/teyro-labs-private-limited/8744f9fc-f440-4610-ac34-05b15c46173b) - [Catalent Maryland, Inc.](https://www.keypedia.com/companies/catalent-maryland-inc/b2f722ce-b6bd-42e6-b648-cec5c4b5f44d) - [Mankind Pharma Limited](https://www.keypedia.com/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777) - [Strides Pharma Science Limited](https://www.keypedia.com/companies/strides-pharma-science-limited/8cbbf469-967b-461a-9ab3-357517269fe2) - [Stira Pharmaceuticals LLC](https://www.keypedia.com/companies/stira-pharmaceuticals-llc/5e44f5bb-4d18-40fa-b93c-7510e3099999) ## Related Officers - [Sandra A. Hughes](https://www.keypedia.com/people/sandra-a-hughes/ee1b9542-fe28-4618-a666-67a1ff736481) - [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e) - [Miguel A. Martinez](https://www.keypedia.com/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5) - [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)